vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and PEOPLES BANCORP OF NORTH CAROLINA INC (PEBK). Click either name above to swap in a different company.

PEOPLES BANCORP OF NORTH CAROLINA INC is the larger business by last-quarter revenue ($21.5M vs $19.2M, roughly 1.1× CuriosityStream Inc.). PEOPLES BANCORP OF NORTH CAROLINA INC runs the higher net margin — 30.8% vs -19.7%, a 50.5% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs 5.6%). PEOPLES BANCORP OF NORTH CAROLINA INC produced more free cash flow last quarter ($20.0M vs $3.9M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs 4.2%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

PEOPLES BANCORP OF NORTH CAROLINA INC is a regional bank holding company headquartered in North Carolina, U.S. It offers a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving local residents, small and medium-sized enterprises, and community organizations across its operating areas in North Carolina.

CURI vs PEBK — Head-to-Head

Bigger by revenue
PEBK
PEBK
1.1× larger
PEBK
$21.5M
$19.2M
CURI
Growing faster (revenue YoY)
CURI
CURI
+30.2% gap
CURI
35.8%
5.6%
PEBK
Higher net margin
PEBK
PEBK
50.5% more per $
PEBK
30.8%
-19.7%
CURI
More free cash flow
PEBK
PEBK
$16.0M more FCF
PEBK
$20.0M
$3.9M
CURI
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
4.2%
PEBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
PEBK
PEBK
Revenue
$19.2M
$21.5M
Net Profit
$-3.8M
$6.6M
Gross Margin
Operating Margin
-17.6%
40.7%
Net Margin
-19.7%
30.8%
Revenue YoY
35.8%
5.6%
Net Profit YoY
-34.6%
86.4%
EPS (diluted)
$-0.07
$1.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
PEBK
PEBK
Q4 25
$19.2M
$21.5M
Q3 25
$18.4M
$21.4M
Q2 25
$19.0M
$20.7M
Q1 25
$15.1M
$20.0M
Q4 24
$14.1M
$20.4M
Q3 24
$12.6M
$20.5M
Q2 24
$12.4M
$20.1M
Q1 24
$12.0M
$19.8M
Net Profit
CURI
CURI
PEBK
PEBK
Q4 25
$-3.8M
$6.6M
Q3 25
$-3.7M
$3.7M
Q2 25
$784.0K
$5.2M
Q1 25
$319.0K
$4.3M
Q4 24
$-2.8M
$3.6M
Q3 24
$-3.1M
$4.0M
Q2 24
$-2.0M
$4.9M
Q1 24
$-5.0M
$3.9M
Operating Margin
CURI
CURI
PEBK
PEBK
Q4 25
-17.6%
40.7%
Q3 25
-24.5%
22.4%
Q2 25
2.5%
32.2%
Q1 25
0.5%
28.2%
Q4 24
-27.4%
22.5%
Q3 24
-25.8%
26.0%
Q2 24
-20.6%
31.3%
Q1 24
-30.4%
23.9%
Net Margin
CURI
CURI
PEBK
PEBK
Q4 25
-19.7%
30.8%
Q3 25
-20.4%
17.2%
Q2 25
4.1%
24.9%
Q1 25
2.1%
21.8%
Q4 24
-19.9%
17.5%
Q3 24
-24.3%
19.3%
Q2 24
-16.4%
24.4%
Q1 24
-42.0%
19.9%
EPS (diluted)
CURI
CURI
PEBK
PEBK
Q4 25
$-0.07
$1.21
Q3 25
$-0.06
$0.67
Q2 25
$0.01
$0.95
Q1 25
$0.01
$0.79
Q4 24
$-0.05
$0.65
Q3 24
$-0.06
$0.72
Q2 24
$-0.04
$0.89
Q1 24
$-0.09
$0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
PEBK
PEBK
Cash + ST InvestmentsLiquidity on hand
$27.3M
$58.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$157.1M
Total Assets
$75.7M
$1.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
PEBK
PEBK
Q4 25
$27.3M
$58.1M
Q3 25
$27.8M
Q2 25
$28.1M
Q1 25
$33.4M
Q4 24
$32.1M
$59.3M
Q3 24
$33.2M
$73.2M
Q2 24
$39.5M
Q1 24
$38.8M
Stockholders' Equity
CURI
CURI
PEBK
PEBK
Q4 25
$41.5M
$157.1M
Q3 25
$47.2M
$149.5M
Q2 25
$49.8M
$144.0M
Q1 25
$58.1M
$138.5M
Q4 24
$57.8M
$130.6M
Q3 24
$62.2M
$136.3M
Q2 24
$64.8M
$124.3M
Q1 24
$67.0M
$121.1M
Total Assets
CURI
CURI
PEBK
PEBK
Q4 25
$75.7M
$1.7B
Q3 25
$74.7M
$1.7B
Q2 25
$78.7M
$1.7B
Q1 25
$85.3M
$1.7B
Q4 24
$86.2M
$1.7B
Q3 24
$87.6M
$1.7B
Q2 24
$90.9M
$1.7B
Q1 24
$94.6M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
PEBK
PEBK
Operating Cash FlowLast quarter
$4.0M
$21.4M
Free Cash FlowOCF − Capex
$3.9M
$20.0M
FCF MarginFCF / Revenue
20.5%
92.7%
Capex IntensityCapex / Revenue
0.1%
6.6%
Cash ConversionOCF / Net Profit
3.22×
TTM Free Cash FlowTrailing 4 quarters
$34.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
PEBK
PEBK
Q4 25
$4.0M
$21.4M
Q3 25
$4.4M
$4.7M
Q2 25
$2.8M
$5.5M
Q1 25
$1.9M
$5.9M
Q4 24
$3.0M
$20.6M
Q3 24
$2.3M
$4.9M
Q2 24
$2.2M
$6.7M
Q1 24
$666.0K
$3.7M
Free Cash Flow
CURI
CURI
PEBK
PEBK
Q4 25
$3.9M
$20.0M
Q3 25
$4.4M
Q2 25
$5.4M
Q1 25
$1.8M
$5.2M
Q4 24
$20.0M
Q3 24
$4.7M
Q2 24
$6.6M
Q1 24
$3.5M
FCF Margin
CURI
CURI
PEBK
PEBK
Q4 25
20.5%
92.7%
Q3 25
20.4%
Q2 25
25.9%
Q1 25
12.2%
25.8%
Q4 24
98.0%
Q3 24
22.9%
Q2 24
32.7%
Q1 24
17.9%
Capex Intensity
CURI
CURI
PEBK
PEBK
Q4 25
0.1%
6.6%
Q3 25
0.0%
1.5%
Q2 25
0.0%
0.5%
Q1 25
0.5%
3.8%
Q4 24
0.0%
2.9%
Q3 24
0.0%
1.0%
Q2 24
0.0%
0.4%
Q1 24
0.0%
0.6%
Cash Conversion
CURI
CURI
PEBK
PEBK
Q4 25
3.22×
Q3 25
1.27×
Q2 25
3.56×
1.06×
Q1 25
6.03×
1.36×
Q4 24
5.78×
Q3 24
1.24×
Q2 24
1.36×
Q1 24
0.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons